Development and Validation of UV-Visible and First-Derivative Spectrophotometric Methods for the Determination of Chlorpromazine in Tablet and Ampoule Dosage Forms
Pharmata · 13.11.2026 · 6 (3) · 112-121
DOI: 10.62425/pharmata.2021205 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmata, online erschienen am 13.11.2026. Verfasst von Elif Nilay Kaya und 1 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Gefördert von: Not applicable.
Abstract (Originalsprache)
Objective
This study aimed to develop and validate simple, sensitive, and cost-effective UV-Visible and first-derivative spectrophotometric methods for the quantitative determination of chlorpromazine in pharmaceutical dosage forms.
Methods
The UV-Visible spectrophotometric method was performed at 254 nm, whereas the first-derivative spectrophotometric method was evaluated at wavelengths of 247 nm and 261 nm. Both methods were comprehensively validated according to ICH Q2(R1) guidelines with respect to linearity, accuracy, precision, limit of detection and limit of quantification.
Results
Linearity was achieved over the concentration range of 1-25 μg/mL for all proposed procedures. The developed methods demonstrated satisfactory accuracy, with relative error values ranging from -1.87% to 6.64%, and acceptable precision, with relative standard deviation values ranging from 0.04% to 8.64% across intra-day and inter-day evaluations. The limits of detection (LOD) and quantification (LOQ) were calculated as 0.29 μg/mL and 0.89 μg/mL, respectively. The first-derivative spectrophotometric approach provided improved spectral resolution and reduced the influence of potential spectral overlap from formulation components. The validated methods were successfully applied to the determination of chlorpromazine in tablet and ampoule pharmaceutical preparations.
Conclusion
The obtained results indicate that the proposed spectrophotometric methods provide rapid, reliable and economical alternatives for routine pharmaceutical quality
Förderung
- Not applicable
Zitieren
APA
Kaya, E. N., & Aşcı, A. (2026). Development and Validation of UV-Visible and First-Derivative Spectrophotometric Methods for the Determination of Chlorpromazine in Tablet and Ampoule Dosage Forms. Pharmata, 6(3), 112-121. https://doi.org/10.62425/pharmata.2021205
Vancouver
Kaya EN, Aşcı A. Development and Validation of UV-Visible and First-Derivative Spectrophotometric Methods for the Determination of Chlorpromazine in Tablet and Ampoule Dosage Forms. Pharmata. 2026;6(3):112-121. doi:10.62425/pharmata.2021205
BibTeX
@article{Kaya2026,
author = {Kaya, Elif Nilay and Aşcı, Ali},
title = {Development and Validation of UV-Visible and First-Derivative Spectrophotometric Methods for the Determination of Chlorpromazine in Tablet and Ampoule Dosage Forms},
journal = {Pharmata},
year = {2026},
volume = {6},
number = {3},
pages = {112--121},
doi = {10.62425/pharmata.2021205}
}
EUVIMED